<?xml version="1.0" encoding="UTF-8"?>
<document id="DrugDDI.d218" origId="Cabergoline"><sentence id="DrugDDI.d218.s0" origId="s0" text="DOSTINEX should not be administered concurrently with D2-antagonists, such as phenothiazines, butyrophenones, thioxanthines, or metoclopramide."><entity id="DrugDDI.d218.s0.e0" origId="s0.p0" charOffset="0-8" type="drug" text="DOSTINEX"/><entity id="DrugDDI.d218.s0.e1" origId="s0.p7" charOffset="78-92" type="drug" text="phenothiazines"/><entity id="DrugDDI.d218.s0.e2" origId="s0.p8" charOffset="94-108" type="drug" text="butyrophenones"/><entity id="DrugDDI.d218.s0.e3" origId="s0.p11" charOffset="128-142" type="drug" text="metoclopramide"/><pair id="DrugDDI.d218.s0.p0" e1="DrugDDI.d218.s0.e0" e2="DrugDDI.d218.s0.e1" interaction="?"/><pair id="DrugDDI.d218.s0.p1" e1="DrugDDI.d218.s0.e0" e2="DrugDDI.d218.s0.e2" interaction="?"/><pair id="DrugDDI.d218.s0.p2" e1="DrugDDI.d218.s0.e0" e2="DrugDDI.d218.s0.e3" interaction="?"/><pair id="DrugDDI.d218.s0.p3" e1="DrugDDI.d218.s0.e1" e2="DrugDDI.d218.s0.e2" interaction="?"/><pair id="DrugDDI.d218.s0.p4" e1="DrugDDI.d218.s0.e1" e2="DrugDDI.d218.s0.e3" interaction="?"/><pair id="DrugDDI.d218.s0.p5" e1="DrugDDI.d218.s0.e2" e2="DrugDDI.d218.s0.e3" interaction="?"/></sentence></document>